The success of inhibition of the proteasome by formation of covalent bonds is a major victory over the long held-view that this would lead to binding the wrong targets and undoubtedly lead to toxicity. Great challenges are now found in uncovering ensembles of new moieties capable of forming long lasting ties. We have introduced peptido sulfonyl fluorides for this purpose. Tuning the reactivity of this electrophilic trap may be crucial for modulating the biological action. Here we describe incorporation of a vinyl moiety into a peptido sulfonyl fluoride backbone, which should lead to a combined attack of the proteasome active site threonine on the double bond and the sulfonyl fluoride. Although this led to strong proteasome inhibitors, in vi...
Peptido sulfonyl fluorides are a relatively new class of protease inhibitors which have ...
The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood c...
The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood c...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
Sulfonyl fluorides have recently been described as “privileged warheads” in chemical biology due to ...
Sulfonyl fluorides have recently been described as “privileged warheads” in chemical biology due to ...
Peptido sulfonyl fluoride derivatives were designed and synthesized containing a substituent on the ...
A unique category of basic side chain containing amino acid derived sulfonyl fluorides (SFs) has bee...
A new class of potent proteasome inhibitors is described, of which the members contain an amino acid...
A new class of potent proteasome inhibitors is described, of which the members contain an amino acid...
Peptido sulfonyl fluorides are a relatively new class of protease inhibitors which have ...
Peptido sulfonyl fluorides are a relatively new class of protease inhibitors which have ...
The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood c...
The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood c...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over t...
Sulfonyl fluorides have recently been described as “privileged warheads” in chemical biology due to ...
Sulfonyl fluorides have recently been described as “privileged warheads” in chemical biology due to ...
Peptido sulfonyl fluoride derivatives were designed and synthesized containing a substituent on the ...
A unique category of basic side chain containing amino acid derived sulfonyl fluorides (SFs) has bee...
A new class of potent proteasome inhibitors is described, of which the members contain an amino acid...
A new class of potent proteasome inhibitors is described, of which the members contain an amino acid...
Peptido sulfonyl fluorides are a relatively new class of protease inhibitors which have ...
Peptido sulfonyl fluorides are a relatively new class of protease inhibitors which have ...
The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood c...
The concept of proteasome inhibition ranks among the latest achievements in the treatment of blood c...